# Seven new tumor cases reported among patients on Novartis’ Zolgensma gene therapy

> **Open Intelligence Dossier** · First detected: 2026-11-06 11:00 UTC · Category: Business

## Executive Summary
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Seven new tumor cases reported among patients on Novartis’ Zolgensma gene therapy&quot; is generating significant coverage in the Business category, with 1 articles from 1 distinct sources tracked by PULSE so far.


Outlets currently covering the story include STAT. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| STAT | Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxOZG5ZNDRuckF0VnFtY2U5UDBLUXZOSEQ2YmtTTU9JZnk1cTVaQVFuYTFaQTFHTjNaMmxFb042U1ZKM1g3X00teG9DWVp1Yk9FWW0xUUYxc1dBNFQwYjRySlBuN1piZ09JdHlXWEFuT0JBZkZCREtVZHFPQUVPaWktSmxpbGs?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-11-06/seven-new-tumor-cases-reported-among-patients-on-novartis-zolgensma-gene-therapy*
